Lack of Association between BDNF rs6265 and Multiple Sclerosis: A Case-Control Study

Area of Science:

• Neurogenetics
• Immunology
• Human Genetics

Background:

• The genetic underpinnings of multiple sclerosis (MS) are complex and not fully understood.
• Brain-Derived Neurotrophic Factor (BDNF) gene variants, specifically rs6265, have been investigated for their potential role in various neurological conditions.
• Existing data on the association between BDNF rs6265 and MS are limited and present conflicting results.

Purpose of the Study:

• To investigate the association between the BDNF rs6265 polymorphism and the risk of developing multiple sclerosis.
• To explore the relationship between BDNF rs6265 and secondary outcomes including age of MS onset, presence of spinal lesions, and clinical manifestations at onset.

Main Methods:

• A case-control study was conducted with 200 newly diagnosed MS patients and 205 healthy controls.
• Genotyping for the BDNF rs6265 polymorphism was performed.
• Statistical analyses included logistic regression and Cox-proportional models to assess associations with MS risk and clinical parameters.

Main Results:

• No statistically significant association was found between the BDNF rs6265 polymorphism and the risk of multiple sclerosis across various genetic models.
• The rs6265 polymorphism was not significantly related to the age of MS onset in either unadjusted or sex-adjusted analyses.
• No association was observed between rs6265 and the presence of spinal lesions or specific clinical manifestations at the time of MS onset.

Conclusions:

• The BDNF rs6265 polymorphism does not appear to be associated with the risk of multiple sclerosis.
• This genetic variant is not linked to the age of onset, spinal lesion presence, or initial clinical presentation in MS patients.
• Further investigation into other genetic factors influencing MS susceptibility and progression is warranted.